Viibryd
Product Images NDC 0456-1101
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Viibryd (NDC 0456-1101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Effect Of Other Drugs On Vilazodone Pharmacokinetics (Viibryd 02)
Figure 2. Impact Of Vilazodone On Other Drug Pharmacokinetics (Viibryd 03)
Figure 3: Impact Of Intrinsic Factors On Vilazodone Pharmacokinetics (Viibryd 04)
Ndc 0456-1110-30rx Only30 Tablets Viibryd®vilazodone HCltablets10 mgdispense The Accompanyingmedication Guide To Each Patientv (Viibryd 05)
Ndc 0456-1120-30rx Only30 Tablets Viibryd®vilazodone HCltablets20 mgdispense The Accompanyingmedication Guide To Each Patient (Viibryd 06)
Ndc 0456-1140-30rx Only30 Tablets Viibryd®vilazodone HCltablets40 mgdispense The Accompanyingmedication Guide To Each Patient (Viibryd 07)
Rx Only Ndc 0456-1100-31viibryd® (Viibryd 08)
Rx Only Ndc 0456-1101-30viibryd® (Viibryd 09)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.